Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05003778 · ClinicalTrials.gov registry record · NA
Minimal Equipment Training Approach to Improve Warfighter Performance
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT05003778 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 54 participants.
The verdict
NCT05003778, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this project is to compare a minimal equipment training program with and without blood flow restriction (BFR) training to periodized concurrent resistance and endurance training. The outcomes of interest are Army Combat Fitness Test (ACFT) performance along with laboratory measures of performance, which include body composition, power, strength, and maximal aerobic capacity (VO2max). Additionally, based on the role of mechanical tension in connective tissue adaptation and the importance for chronic musculoskeletal health, tendon architecture will be assessed as well. Lastly, specific blood-based biomarkers will be analyzed in conjunction with questionnaires to determine the systemic physiological and psychological responses to training. Participants will be randomized into one of three training groups and will follow their respective program for 6 weeks. The three groups are traditional concurrent resistance and endurance training, minimal equipment training, and minimal equipment training with blood flow restriction (BFR).
Interventions
- OTHER Blood flow restriction training
- OTHER Traditional equipment resistance training
- OTHER Minimal equipment resistance training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2022-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05003778
The ClinicalTrials.gov registry entry for NCT05003778 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood flow restriction training is the first listed.
NCT05003778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05003778 about?
NCT05003778 is a clinical study titled "Minimal Equipment Training Approach to Improve Warfighter Performance". The purpose of this project is to compare a minimal equipment training program with and without blood flow restriction (BFR) training to periodized concurrent resistance and endurance training. The outcomes of interest are Army Combat Fitness Test (ACFT) performance along with laboratory measures of...
What is the current status of trial NCT05003778?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2020-11-20. Estimated completion is 2022-06-29.
What interventions are being tested in trial NCT05003778?
The interventions under investigation include: Blood flow restriction training (OTHER), Traditional equipment resistance training (OTHER), Minimal equipment resistance training (OTHER).
Who is sponsoring clinical trial NCT05003778?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.